Try our Advanced Search for more refined results

Deals Rumor Mill: Teva, ConvaTec, Abraaj

By Matthew Perlman (May 13, 2016, 6:16 PM EDT) -- Mylan NV and Novartis AG are among possible suitors exploring a purchase of Teva Pharmaceutical Industries Ltd.'s portfolio of drugs in the U.K., Ireland and Iceland, a Bloomberg report said Friday. Teva could bring in as much as $2 billion for the businesses, which are also seeing interest from private equity investors Apollo Global Management LLC and Cinven Ltd., according to the report. The company is working with Greenhill & Co. to find a buyer, in order to win regulatory approval for its planned $40.5 billion acquisition of Allergan PLC's generics business, the report said....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!